Literature DB >> 24974012

Structural features of ultradeformable archaeosomes for topical delivery of ovalbumin.

Dolores C Carrer1, Leticia H Higa2, Maria Victoria Defain Tesoriero3, Maria Jose Morilla2, Diana I Roncaglia2, Eder Lilia Romero4.   

Abstract

The ultradeformable archaeosomes (UDA, made of total polar archaeolipids (TPA) extracted from the extreme halophile archaea Halorubrum tebenquichense:soybean phosphatidylcholine (SPC):sodium cholate (NaChol), 3:3:1 w:w), are promising topical adjuvants showing high deformability, an essential property for intact skin penetration up to the viable epidermis/dermis. To gain insights on UDA structure, the interactions between TPA, SPC and the edge activator NaChol, were assessed by electrospray ionization mass spectroscopy (ESI-MS) and confocal fluorescence microscopy of giant unilamellar vesicles (GUV). The non covalent heterodimers NaChol-SPC, NaChol-phosphatidylglycerophosphate methyl ether (PGPMe), NaChol-sulfated diglycosyl diphytanyl-glycerol diether (SDGD5) and SPC-PGPMe detected in the gas phase by ESI-MS after direct infusion of UDA, together with the homogeneous partition of FASTDiO and DiIC18 in GUV suggested that in these proportions, lipids and NaChol were miscible. We propose therefore, a model where in UDA the SPC diluted sufficient enough in the rich PGPMe TPA, so as to the low lateral mobility of molecules (typical of rich in PGPMe bilayers) was no longer experienced. We also found that 50μm deep within in vitro human skin canyons, the fluorescence of Alexa fluor 647-ovalbumin in UDL was ∼1.5 folds higher than in UDA, indicating a potential steric hindrance of the voluminous structure of PGPMe UDA bilayer, to the penetration of a particulate cargo such as the 7nm diameter ovalbumin. According to these observations, a further reduction in PGPMe - a lipid playing no immune role - content could help to improve the performance of UDA as topical adjuvants.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Penetration; Skin; Ultradeformable archaeosomes

Mesh:

Substances:

Year:  2014        PMID: 24974012     DOI: 10.1016/j.colsurfb.2014.05.015

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  6 in total

1.  Enhanced photodynamic leishmanicidal activity of hydrophobic zinc phthalocyanine within archaeolipids containing liposomes.

Authors:  Ana Paula Perez; Agustina Casasco; Priscila Schilrreff; Maria Victoria Defain Tesoriero; Luc Duempelmann; Juan Sebastián Pappalardo; Maria Julia Altube; Leticia Higa; Maria Jose Morilla; Patricia Petray; Eder L Romero
Journal:  Int J Nanomedicine       Date:  2014-07-10

2.  Evidence of Skin Barrier Damage by Cyclic Siloxanes (Silicones)-Using Digital Holographic Microscopy.

Authors:  Krystyna Mojsiewicz-Pieńkowska; Ewa Stachowska; Dominika Krenczkowska; Dagmara Bazar; Frans Meijer
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

3.  The Anti-Inflammatory Effect of Nanoarchaeosomes on Human Endothelial Cells.

Authors:  Nancy Charó; Horacio Jerez; Silvio Tatti; Eder Lilia Romero; Mirta Schattner
Journal:  Pharmaceutics       Date:  2022-03-29       Impact factor: 6.525

4.  Preparation and Optimization of an Ultraflexible Liposomal Gel for Lidocaine Transdermal Delivery.

Authors:  Mengwei Sun; Ositomiwa O Osipitan; Ewa K Sulicz; Anthony J Di Pasqua
Journal:  Materials (Basel)       Date:  2022-07-14       Impact factor: 3.748

5.  Ultradeformable Archaeosomes for Needle Free Nanovaccination with Leishmania braziliensis Antigens.

Authors:  Leticia H Higa; Laura Arnal; Mónica Vermeulen; Ana Paula Perez; Priscila Schilrreff; Cecilia Mundiña-Weilenmann; Osvaldo Yantorno; María Elena Vela; María José Morilla; Eder Lilia Romero
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

6.  Liposomes can both enhance or reduce drugs penetration through the skin.

Authors:  Ma F Peralta; Ma L Guzmán; A P Pérez; G A Apezteguia; Ma L Fórmica; E L Romero; Ma E Olivera; D C Carrer
Journal:  Sci Rep       Date:  2018-09-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.